2022-2029 年肺炎药物全球市场规模研究与预测，按药物、分销渠道、年龄组、地区分析

2021 年全球肺炎药物市场价值约为 132.4 亿美元，预计在 2022-2029 年预测期内将以超过 8.5% 的健康增长率增长。

肺炎是一种急性呼吸道感染，会导致由细菌、病毒或真菌引起的一个或两个肺部气囊发炎。肺炎的症状包括咳嗽时伴有绿色、黄色、带血的粘液、发烧、出汗、呼吸急促、呼吸急促而浅，以及胸口刺痛。肺炎病例数量的增加、未满足的需求增加以及主要参与者的战略举措是推动市场增长的主要因素。

根据联合国儿童基金会的数据 - 截至 2019 年，全球每年约有 700,000 名五岁以下儿童死亡，每天约有 2,000 人死亡。南亚也是受影响最严重的地区（每 100,000 名儿童 2,500 例），其次是西非和中非（每 100,000 名儿童 1,620 例）。此外，由于新兴国家的医疗费用上涨以及製药领域的积极研发活动，预计该市场在预测期内将大幅增长。然而，高昂的治疗成本和缺乏对预防疫苗的认识将阻碍整个 2022-2029 年预测期内的市场增长。

全球肺炎药物市场研究中考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。由于大型製药公司的存在以及该地区强大的医疗基础设施的可用性，北美已成为收入方面的关键地区。另一方面，由于老年人口增加和小儿肺炎增加等因素，预计亚太地区在预测期内将显着增长。

本报告中包含的主要市场参与者包括：

• Abbott Laboratories
• Bayer AG
• Eli Lilly & Company
• GlaxoSmithKline PLC.
• Lupin Pharmaceuticals, Inc.
• Merck KGAA
• Novartis AG
• Pfizer, Inc.
• Sanofi S.A.
• Teva Pharmaceuticals Industries Limited.

市场的最新发展。

• 2020 年 12 月，总部位于印度的印度血清研究所推出了第一种本土肺炎疫苗。这种新疫苗将在联合国儿童基金会网络的帮助下提供给世界各地的儿童。
• 2021 年 7 月，美国默克公司在 18 岁及以上的成年人中鑑定出肺炎球菌血清型 1、3、4、5、6A、6B、7F、9V、14、18C、19A、19F、22F 和 23F . 已获得美国食品和药物管理局 (FDA) 批准用于预防 33F 特异性侵袭性疾病的新型 VAXNEUVANCE□（肺炎球菌 15 价结合疫苗）。

全球肺炎药物市场研究范围。

历史数据：2019-2020-2021

基本估计年份：2021

预测期间：2022-2029

报告涵盖的收入预测、公司排名、竞争格局、增长因素、趋势

目标细分治疗药物、分销渠道、年龄组、地区

区域范围北美、欧洲、亚太地区、拉丁美洲、世界其他地区

购买后可免费定制覆盖率报告（最多 8 小时的分析师工作）。添加或更改国家、地区、细分范围*

这项研究的目的是定义近年来各个细分市场和国家的市场规模，并预测他们在未来几年的价值。该报告旨在捕捉被调查国家工业的定性和定量方面。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。此外，它还包含供利益相关者投资的微观市场潜在机会，以及对主要参与者的竞争格局和产品供应的深入分析。市场的详细细分和子细分如下所述。

按药物

预防疫苗

治疗

按销售渠道

医院

药品分销商

杂项

按年龄段

儿科

成人

老年

按地区

北美

美国

加拿大

欧洲

英国

德国

法国

西班牙

意大利

其他欧洲

亚太地区

中国

印度

日本

澳大利亚

韩国

其他亚太地区

拉丁美洲

巴西

墨西哥

世界其他地区

内容

第 1 章执行摘要

• 市场概况
• 2019-2029 年各细分市场的全球市场估计和预测
  • 肺炎药物市场（按地区）：2019-2029
  • 肺炎药物市场（按药物分类）：2019-2029
  • 肺炎药物市场（按分销渠道）：2019-2029
  • 肺炎药物市场（按年龄组）：2019-2029
• 主要趋势
• 调查方法
• 调查先决条件

第2章肺炎药物的全球市场定义和范围

• 调查的目的
• 市场定义和范围
  • 调查范围
  • 工业发展
• 调查年份
• 货币兑换率

第三章全球肺炎药物市场动态

• 肺炎药品市场影响分析（2019-2029）
  • 市场驱动因素
    • 肺炎病例增加
    • 不断增长的未满足需求
    • 主要市场参与者的战略举措
  • 市场挑战
    • 高昂的治疗费用
    • 缺乏对预防疫苗的认识
  • 市场机会
    • 发展中地区的医疗支出增加
    • 在製药领域开展研发活动

第四章肺炎药物全球市场行业分析

• 波特 5 力模型
  • 供应商的议价能力
  • 买家的议价能力
  • 新进入者的威胁
  • 替代品的威胁
  • 竞争公司之间的敌对关係
• 波特 5 力模型的未来方法 (2019-2029)
• 害虫分析
  • 政治
  • 经济的
  • 社交
  • 技术
• 投资招聘模式
• 分析师的结论和建议
• 顶级投资机会
• 关键成功策略

第 5 章风险评估：COVID-19 的影响

• 评估 COVID-19 对行业的总体影响
• COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球肺炎药物市场，按药物分类

• 市场概况
• 全球肺炎药物市场：按药物、性能-潜力分析
• 2019-2029 年全球肺炎药物市场、按药物分类的估计和预测
• 肺炎药物市场，细分市场分析
  • 预防性疫苗
  • 治疗药物

第 7 章：肺炎药物的全球市场：按分销渠道分类

• 市场概况
• 肺炎药物的全球市场：按分销渠道进行的性能潜力分析
• 2019-2029 年全球肺炎药物市场，按分销渠道估计和预测
• 肺炎药物市场，细分市场分析
  • 医院
  • 药店
  • 其他

第 8 章全球肺炎药物市场：按年龄组分类

• 市场概况
• 肺炎药物的全球市场：按年龄组划分），性能潜力分析
• 按年龄组划分的肺炎药物全球市场、估计和预测 (2019-2029)
• 肺炎药物市场，细分市场分析
  • 儿科
  • 成人
  • 年老

第 9 章全球肺炎药物市场：区域分析

• 肺炎药物市场，按地区划分的市场概况
• 北美
  • 美国
    • 2019-2029 年各治疗药物的估计和预测
    • 2019-2029 年各分销渠道的估计和预测
    • 2019-2029 年各年龄段的估计和预测
  • 加拿大
• 欧洲肺炎药物市场概况
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 意大利
  • 其他欧洲地区
• 亚太肺炎药物市场概况
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 韩国
  • 其他亚太地区
• 拉丁美洲的肺炎药物市场概况
  • 巴西
  • 墨西哥
• 世界其他地区

第 10 章衝突信息

• 顶级市场策略
• 公司简介
  • 雅培实验室
    • 主要信息
    • 概览
    • 财务（如果有数据）
    • 产品概览
    • 近期发展状况
  • Bayer AG
  • Eli Lilly & Company
  • GlaxoSmithKline PLC.
  • Lupin Pharmaceuticals, Inc.
  • Merck KGAA
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi S.A.
  • Teva Pharmaceuticals Industries Limited.

第 11 章研究过程

• 研究过程
  • 数据挖掘
  • 分析
  • 市场评估
  • 验证
  • 出版
• 调查属性
• 调查先决条件

Global Pneumonia Therapeutics Market is valued approximately USD 13.24 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2022-2029. Pneumonia is a type of acute respiratory infection that inflames the air sacs in one or both lungs caused by bacteria, viruses, or fungi. The signs and symptoms of Pneumonia include cough, with greenish, yellow, and bloody mucus, fever, sweating, shortness of breath, rapid, shallow breathing, and stabbing chest pain among others. The increasing incidences of pneumonia and growing unmet clinical needs as well as strategic initiatives from leading market players are key factors accelerating the market growth.

According to UNICEF - as of 2019, globally around 700,000 children under five lost their lives every year, accounting for around 2,000 deaths every day. In addition, South Asia (2,500 cases per 100,000 children) is the most affected region followed by West and Central Africa (1,620 cases per 100,000 children). Also, rising healthcare spending in developing regions and growing number of R&D activities in pharmaceuticals sector would create lucrative growth prospectus for the market over the forecast period. However, a high treatment cost and lack of awareness towards preventive vaccines impede the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Pneumonia Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region in terms of revenue due to presence of leading pharmaceutical giants as well as availability of robust healthcare infrastructure in the region. Whereas Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric population and increasing prevalence of pneumonia in children in the region.

Major market players included in this report are:

Abbott Laboratories

Bayer AG

Eli Lilly & Company

GlaxoSmithKline PLC.

Lupin Pharmaceuticals, Inc.

Merck KGAA

Novartis AG

Pfizer, Inc.

Sanofi S.A.

Teva Pharmaceuticals Industries Limited.

Recent Developments in the Market:

• In December 2020, India based Serum Institute of India launched first indigenous vaccine for pneumonia. The new vaccines would be provided for children throughout the world with the help of UNICEF network.
• In July 2021, US based Merck received the U.S. Food and Drug Administration (FDA) approval for its new VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) intended for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in adults 18 years of age and older.

Global Pneumonia Therapeutics Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered Therapeutics, Distribution Channel, Age Group, Region

Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapeutics

Prevention Vaccines

Treatment Drugs

By Distribution Channel

Hospitals

Pharmaceutical Stores

Other

By Age Group

Pediatric

Adult

Geriatric

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Pneumonia Therapeutics Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Pneumonia Therapeutics Market, by Therapeutics, 2019-2029 (USD Billion)
  • 1.2.3. Pneumonia Therapeutics Market, by Distribution Channel, 2019-2029 (USD Billion)
  • 1.2.4. Pneumonia Therapeutics Market, by Age Group, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Pneumonia Therapeutics Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Pneumonia Therapeutics Market Dynamics

• 3.1. Pneumonia Therapeutics Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing incidences of Pneumonia
    • 3.1.1.2. Growing unmet clinical needs
    • 3.1.1.3. Strategic initiatives from leading market players.
  • 3.1.2. Market Challenges
    • 3.1.2.1. High treatment cost.
    • 3.1.2.2. Lack of awareness towards preventive vaccines.
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising healthcare spending in developing regions.
    • 3.1.3.2. Growing number of R&D activities in pharmaceuticals sector.

Chapter 4. Global Pneumonia Therapeutics Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Pneumonia Therapeutics Market, by Therapeutics

• 6.1. Market Snapshot
• 6.2. Global Pneumonia Therapeutics Market by Therapeutics, Performance - Potential Analysis
• 6.3. Global Pneumonia Therapeutics Market Estimates & Forecasts by Therapeutics 2019-2029 (USD Billion)
• 6.4. Pneumonia Therapeutics Market, Sub Segment Analysis
  • 6.4.1. Prevention Vaccines
  • 6.4.2. Treatment Drugs

Chapter 7. Global Pneumonia Therapeutics Market, by Distribution Channel

• 7.1. Market Snapshot
• 7.2. Global Pneumonia Therapeutics Market by Distribution Channel, Performance - Potential Analysis
• 7.3. Global Pneumonia Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
• 7.4. Pneumonia Therapeutics Market, Sub Segment Analysis
  • 7.4.1. Hospitals
  • 7.4.2. Pharmaceutical Stores
  • 7.4.3. Others

Chapter 8. Global Pneumonia Therapeutics Market, by Age Group

• 8.1. Market Snapshot
• 8.2. Global Pneumonia Therapeutics Market by Age Group, Performance - Potential Analysis
• 8.3. Global Pneumonia Therapeutics Market Estimates & Forecasts by Age Group 2019-2029 (USD Billion)
• 8.4. Pneumonia Therapeutics Market, Sub Segment Analysis
  • 8.4.1. Pediatric
  • 8.4.2. Adult
  • 8.4.3. Geriatric

Chapter 9. Global Pneumonia Therapeutics Market, Regional Analysis

• 9.1. Pneumonia Therapeutics Market, Regional Market Snapshot
• 9.2. North America Pneumonia Therapeutics Market
  • 9.2.1. U.S. Pneumonia Therapeutics Market
    • 9.2.1.1. Therapeutics breakdown estimates & forecasts, 2019-2029
    • 9.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.1.3. Age Group breakdown estimates & forecasts, 2019-2029
  • 9.2.2. Canada Pneumonia Therapeutics Market
• 9.3. Europe Pneumonia Therapeutics Market Snapshot
  • 9.3.1. U.K. Pneumonia Therapeutics Market
  • 9.3.2. Germany Pneumonia Therapeutics Market
  • 9.3.3. France Pneumonia Therapeutics Market
  • 9.3.4. Spain Pneumonia Therapeutics Market
  • 9.3.5. Italy Pneumonia Therapeutics Market
  • 9.3.6. Rest of Europe Pneumonia Therapeutics Market
• 9.4. Asia-Pacific Pneumonia Therapeutics Market Snapshot
  • 9.4.1. China Pneumonia Therapeutics Market
  • 9.4.2. India Pneumonia Therapeutics Market
  • 9.4.3. Japan Pneumonia Therapeutics Market
  • 9.4.4. Australia Pneumonia Therapeutics Market
  • 9.4.5. South Korea Pneumonia Therapeutics Market
  • 9.4.6. Rest of Asia Pacific Pneumonia Therapeutics Market
• 9.5. Latin America Pneumonia Therapeutics Market Snapshot
  • 9.5.1. Brazil Pneumonia Therapeutics Market
  • 9.5.2. Mexico Pneumonia Therapeutics Market
• 9.6. Rest of The World Pneumonia Therapeutics Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Abbott Laboratories
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Bayer AG
  • 10.2.3. Eli Lilly & Company
  • 10.2.4. GlaxoSmithKline PLC.
  • 10.2.5. Lupin Pharmaceuticals, Inc.
  • 10.2.6. Merck KGAA
  • 10.2.7. Novartis AG
  • 10.2.8. Pfizer, Inc.
  • 10.2.9. Sanofi S.A.
  • 10.2.10. Teva Pharmaceuticals Industries Limited.

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Pneumonia Therapeutics Market, report scope
• TABLE 2. Global Pneumonia Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Pneumonia Therapeutics Market estimates & forecasts by Therapeutics 2019-2029 (USD Billion)
• TABLE 4. Global Pneumonia Therapeutics Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
• TABLE 5. Global Pneumonia Therapeutics Market estimates & forecasts by Age Group 2019-2029 (USD Billion)
• TABLE 6. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 17. U.S. Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. U.S. Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 19. Canada Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 20. Canada Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. Canada Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 22. UK Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 23. UK Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. UK Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 25. Germany Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 26. Germany Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. Germany Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 28. France Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 29. France Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. France Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 31. Italy Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 32. Italy Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Italy Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 34. Spain Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 35. Spain Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. Spain Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 37. RoE Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 38. RoE Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. RoE Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 40. China Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 41. China Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. China Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 43. India Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 44. India Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. India Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 46. Japan Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 47. Japan Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. Japan Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 49. South Korea Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 50. South Korea Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. South Korea Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 52. Australia Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 53. Australia Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. Australia Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. RoAPAC Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 58. Brazil Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 59. Brazil Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Brazil Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 61. Mexico Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 62. Mexico Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. Mexico Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 64. RoLA Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 65. RoLA Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. RoLA Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 67. Row Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 68. Row Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. Row Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 70. List of secondary sources, used in the study of global Pneumonia Therapeutics Market
• TABLE 71. List of primary sources, used in the study of global Pneumonia Therapeutics Market
• TABLE 72. Years considered for the study
• TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Pneumonia Therapeutics Market, research methodology
• FIG 2. Global Pneumonia Therapeutics Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Pneumonia Therapeutics Market, key trends 2021
• FIG 5. Global Pneumonia Therapeutics Market, growth prospects 2022-2029
• FIG 6. Global Pneumonia Therapeutics Market, porters 5 force model
• FIG 7. Global Pneumonia Therapeutics Market, pest analysis
• FIG 8. Global Pneumonia Therapeutics Market, value chain analysis
• FIG 9. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Pneumonia Therapeutics Market, regional snapshot 2019 & 2029
• FIG 15. North America Pneumonia Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Pneumonia Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Pneumonia Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Pneumonia Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 19. Global Pneumonia Therapeutics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable